Recommendation for Vaccinations in Patients with Crohn
IBDČes a Slov Gastroent a Hepatol 2010; 64(1): 40-48 .
Summarypdf Jiří Stehlík, Karel Mareš, Milan Lukáš, Martin Bortlík, Dana ĎuricováRifaximin in the treatment of Crohn´s disease. Results of the GRACE 02 study
IBDČes a Slov Gastroent a Hepatol 2010; 64(3): 31-36.
Summarypdf Dana Ďuricová, Martin Bortlík, Milan LukášAetiology and pathogenesis of ulcerative colitis. Still more questions than clear answers
Review articleGastroent Hepatol 2011; 65(2): 56-64.
Summarypdf Milan Lukáš, Martin BortlíkWhich non-steroidal anti-inflammatory drug should be used in patients with increased risk of gastrointestinal toxicity?
CommentGastroent Hepatol 2011; 65(3): 159-160.
pdf Martin Bortlík, Milan LukášSingle-balloon enteroscopy in patients with Crohn's disease - single centre's experience
Original articleGastroent Hepatol 2011; 65(4): 215-219.
Summarypdf Naděžda Machková, Martin Bortlík, Eva Bouzková, Dana Ďuricová, Luděk Hrdlička, Milan LukášStenóza terminálního ilea: věk, komorbidity a koincidující medikace jsou významné pro diferenciální diagnózu
QuizGastroent Hepatol 2011; 65(5): 245.
pdf Martin Bortlík, Dana Ďuricová, Ivana Vítková, Zdeněk LukášLow serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2012; 66(1): 23-31.
Summarypdf Karin Malíčková, Dana Ďuricová, Martin Bortlík, Viktor Komárek, Naděžda Machková, Arnošt Komárek, Ivana Janatková, Milan Lukáš